ChartMill assigns a Buy % Consensus number of 85% to FENC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-15 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-15 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-18 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-06 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-04-04 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-22 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2022-10-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-26 | Wedbush | Maintains | Outperform |
| 2022-09-07 | Capital One | Initiate | Overweight |
| 2021-06-03 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-21 | Craig-Hallum | Initiate | Buy |
| 2021-04-19 | Maxim Group | Initiate | Buy |
11 analysts have analysed FENC and the average price target is 13.77 USD. This implies a price increase of 68.13% is expected in the next year compared to the current price of 8.19.
The consensus rating for FENNEC PHARMACEUTICALS INC (FENC) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.